DK1696913T3 - Vinfluninholdigt farmaceutisk præparat til parenteral administration, fremgangsmåde til fremstilling deraf og dets anvendelse - Google Patents

Vinfluninholdigt farmaceutisk præparat til parenteral administration, fremgangsmåde til fremstilling deraf og dets anvendelse

Info

Publication number
DK1696913T3
DK1696913T3 DK04816422T DK04816422T DK1696913T3 DK 1696913 T3 DK1696913 T3 DK 1696913T3 DK 04816422 T DK04816422 T DK 04816422T DK 04816422 T DK04816422 T DK 04816422T DK 1696913 T3 DK1696913 T3 DK 1696913T3
Authority
DK
Denmark
Prior art keywords
vinflunin
preparation
pharmaceutical composition
parenteral administration
containing pharmaceutical
Prior art date
Application number
DK04816422T
Other languages
English (en)
Inventor
Elie Leverd
Marie-Dominique Ibarra
Joel Bougaret
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34630533&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1696913(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of DK1696913T3 publication Critical patent/DK1696913T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
DK04816422T 2003-12-23 2004-12-17 Vinfluninholdigt farmaceutisk præparat til parenteral administration, fremgangsmåde til fremstilling deraf og dets anvendelse DK1696913T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0315312A FR2863891B1 (fr) 2003-12-23 2003-12-23 Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
PCT/FR2004/003287 WO2005070425A1 (fr) 2003-12-23 2004-12-17 Composition pharmaceutique de vinflunine destinee a une administration parenterale, procede de preparation et utilisation

Publications (1)

Publication Number Publication Date
DK1696913T3 true DK1696913T3 (da) 2009-06-29

Family

ID=34630533

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04816422T DK1696913T3 (da) 2003-12-23 2004-12-17 Vinfluninholdigt farmaceutisk præparat til parenteral administration, fremgangsmåde til fremstilling deraf og dets anvendelse

Country Status (35)

Country Link
US (1) US20070155768A1 (da)
EP (1) EP1696913B1 (da)
JP (2) JP5226220B2 (da)
KR (1) KR101166347B1 (da)
CN (2) CN1897940A (da)
AR (1) AR047346A1 (da)
AT (1) ATE424201T1 (da)
AU (1) AU2004314154B2 (da)
BR (1) BRPI0418005B8 (da)
CA (1) CA2551493C (da)
CR (1) CR8473A (da)
CY (1) CY1109120T1 (da)
DE (1) DE602004019809D1 (da)
DK (1) DK1696913T3 (da)
EC (1) ECSP066663A (da)
ES (1) ES2323374T3 (da)
FR (1) FR2863891B1 (da)
HK (1) HK1089105A1 (da)
IL (1) IL176404A (da)
MA (1) MA28237A1 (da)
MX (1) MXPA06007208A (da)
MY (1) MY139643A (da)
NI (1) NI200600146A (da)
NO (1) NO336427B1 (da)
NZ (1) NZ548028A (da)
OA (1) OA13348A (da)
PL (1) PL1696913T3 (da)
PT (1) PT1696913E (da)
RU (1) RU2362557C2 (da)
SI (1) SI1696913T1 (da)
TN (1) TNSN06197A1 (da)
TW (1) TWI334352B (da)
UA (1) UA83888C2 (da)
WO (1) WO2005070425A1 (da)
ZA (1) ZA200605201B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
FR2912406B1 (fr) * 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
EP1997534A1 (en) * 2007-05-31 2008-12-03 Pierre Fabre Medicament Cancer treatment combination therapy comprising vinflunine and trastuzumab
CN101129374B (zh) * 2007-06-26 2010-09-08 齐鲁制药有限公司 长春氟宁药物组合物及其制备方法与应用
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
CN101607968A (zh) * 2008-06-17 2009-12-23 江苏豪森药业股份有限公司 长春氟宁盐、其制备方法及其药物组合物
MA35050B1 (fr) * 2011-03-29 2014-04-03 Sanofi Sa Formulation d'otamixaban ayant une stabilité améliorée
EP3328385B1 (en) * 2015-08-01 2020-07-08 Sun Pharmaceutical Industries Ltd Dosage form of vinca alkaloid drug
WO2018007554A1 (en) * 2016-07-06 2018-01-11 Pierre Fabre Medicament Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307100A (en) * 1978-08-24 1981-12-22 Agence Nationale De Valorisation De La Recherche (Anvar) Nor bis-indole compounds usable as medicaments
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
CA2001643A1 (en) * 1988-12-23 1990-06-23 Richard L. Wolgemuth Preservative-free multi-dose vincristine solution
HU204995B (en) * 1989-11-07 1992-03-30 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
JPH06100452A (ja) * 1993-04-06 1994-04-12 Asta Medica Ag イホスファミド用の製薬学的容器
FR2707988B1 (fr) * 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
DE19706255C2 (de) * 1997-02-18 2000-11-30 Schott Glas Sterilisierbarer Glasbehälter für medizinische Zwecke, insbesondere zur Aufbewahrung pharmazeutischer oder diagnostischer Produkte
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
JP3642492B1 (ja) * 2003-10-31 2005-04-27 小野薬品工業株式会社 オザグレルナトリウム含有水溶液を充填してなる注射用容器
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation

Also Published As

Publication number Publication date
ES2323374T3 (es) 2009-07-14
ATE424201T1 (de) 2009-03-15
TWI334352B (en) 2010-12-11
EP1696913B1 (fr) 2009-03-04
OA13348A (fr) 2007-04-13
SI1696913T1 (sl) 2009-08-31
NZ548028A (en) 2010-01-29
UA83888C2 (ru) 2008-08-26
ECSP066663A (es) 2006-10-25
JP5710462B2 (ja) 2015-04-30
PT1696913E (pt) 2009-06-05
IL176404A (en) 2010-11-30
RU2362557C2 (ru) 2009-07-27
FR2863891B1 (fr) 2006-03-24
JP5226220B2 (ja) 2013-07-03
FR2863891A1 (fr) 2005-06-24
EP1696913A1 (fr) 2006-09-06
NI200600146A (es) 2006-12-12
KR20060124624A (ko) 2006-12-05
AU2004314154B2 (en) 2011-03-24
CR8473A (es) 2006-11-24
CY1109120T1 (el) 2014-07-02
NO20063277L (no) 2006-07-14
PL1696913T3 (pl) 2009-08-31
AU2004314154A1 (en) 2005-08-04
DE602004019809D1 (de) 2009-04-16
BRPI0418005A (pt) 2007-04-17
MXPA06007208A (es) 2006-08-18
RU2006126708A (ru) 2008-01-27
TNSN06197A1 (fr) 2007-11-15
MA28237A1 (fr) 2006-10-02
CN101695474A (zh) 2010-04-21
CN1897940A (zh) 2007-01-17
CA2551493C (fr) 2012-12-04
BRPI0418005B1 (pt) 2019-11-26
MY139643A (en) 2009-10-30
US20070155768A1 (en) 2007-07-05
HK1089105A1 (en) 2006-11-24
NO336427B1 (no) 2015-08-17
TW200531717A (en) 2005-10-01
ZA200605201B (en) 2007-09-26
CA2551493A1 (fr) 2005-08-04
BRPI0418005B8 (pt) 2021-05-25
KR101166347B1 (ko) 2012-07-18
JP2012102120A (ja) 2012-05-31
JP2007515461A (ja) 2007-06-14
IL176404A0 (en) 2006-10-05
AR047346A1 (es) 2006-01-18
WO2005070425A1 (fr) 2005-08-04

Similar Documents

Publication Publication Date Title
DK1490062T3 (da) Glukokortikoidmimetika, fremgangsmåder til fremstilling deraf, farmaceutiske sammensætninger og anvendelser deraf
IL163831A0 (en) Derivatives of aminoindazoles, method of preparation and intermediates of the method as drugs pharmaceutical compounds containing
IS7261A (is) N-adamantýlmetýlafleiður og milliefni sem lyfjablöndur og aðferðir til að framleiða þær
IS8024A (is) Adamantanafleiður, aðferðir til að framleiða þær og lyfjablanda sem inniheldur þær
NO331093B1 (no) Somatostatinanaloger, fremgangsmåte for fremstilling, farmasøytisk sammensetning og anvendelse derav.
DK1673349T3 (da) Benzimidazolderivater: fremstilling og farmaceutiske anvendelser
HK1089105A1 (en) Pharmaceutical composition of vinflunine for parenteral administration, preparation method thereof and use of same
DK1523488T3 (da) Nye thiophenglycosidderivater, fremgangsmåder til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
IS7543A (is) Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær
PL377811A1 (pl) Nowe cykliczne pochodne mocznika, sposób ich wytwarzania i ich zastosowanie farmaceutyczne jako inhibitorów kinazy
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
IL172733A0 (en) Diphenylpyridine derivatives, preparation and therapeutic application thereof
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
DK1414816T3 (da) Stabil polymorf af flibanserin, teknisk fremgangsmåde til fremstilling deraf og anvendelse deraf til lægemiddelfremstilling
NO20053809D0 (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
IL182505A0 (en) Purified phospholipid-non-steroidal, anti-inflammatory drug associated compositions and method for preparing and using same
DK1560826T3 (da) Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse
NO20042272L (no) Farmasoytiske blandinger og fremgangsmater for administrering av EP2-reseptor selektive agonister
GB0608398D0 (en) Pharmaceutical composition and method of using same
IS8164A (is) Hringtengdar amínafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær
DK1783105T3 (da) Mørtelsammensætning, fremgangsmåde til fremstilling og anvendelse deraf
IS7424A (is) Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær
DK1520587T3 (da) Allergivaccinesammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf til allergibehandling
DK1791872T3 (da) Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf